Pharmabiz4m
Dr Reddy's net profit declines 9.4 per cent in Q2FY25
Dr Reddy's Laboratories has reported a decline of 9.36 per cent in net profit at Rs. 1,341.5 crore on a consolidated basis during the second quarter ended September 30, 2024, as compared to Rs. 1,480 ...
Dr Reddys Laboratories Ltd spurts 2.25%
Dr Reddys Laboratories Ltd is quoting at Rs 1300.85, up 2.25% on the day as on 12:49 IST on the NSE. The stock is up 20.35% in last one year as compared to a 25.83% spurt in NIFTY and a 49.79% spurt ...
Hold Dr Reddy’s Laboratories; target of Rs 1270: ICICI Securities
Dr. Reddy’s Laboratories’ (DRL) Q2FY25 performance, adjusted for acquisition-related expenses (INR 561mn) and impairment ...